Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.

about

Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.

Item

http://www.wikidata.org/entity/Q41564670

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Treatment strategies in patien ...... drome relapsed after Allo-SCT.

@en

type

Item

label

Treatment strategies in patien ...... drome relapsed after Allo-SCT.

@en

prefLabel

Treatment strategies in patien ...... drome relapsed after Allo-SCT.

@en

P1476

Treatment strategies in patien ...... drome relapsed after Allo-SCT.

@en

P2093

C Groth

http://www.w3.org/2001/XMLSchema#string

C Müller-Tidow

http://www.w3.org/2001/XMLSchema#string

F Rosenow

http://www.w3.org/2001/XMLSchema#string

G Evers

http://www.w3.org/2001/XMLSchema#string

G Silling

http://www.w3.org/2001/XMLSchema#string

M Stelljes

http://www.w3.org/2001/XMLSchema#string

R Besoke

http://www.w3.org/2001/XMLSchema#string

R M Mesters

http://www.w3.org/2001/XMLSchema#string

T Büchner

http://www.w3.org/2001/XMLSchema#string

T Sauer

http://www.w3.org/2001/XMLSchema#string

P2860

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Chimeric antigen receptor T cells for sustained remissions in leukemia

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr

Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.

Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial.

P2888

bmt.2014.300

P304

485-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2014.300

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Torsten Kessler

Jörn C Albring

Dennis Görlich

P577

2015-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030241187

http://www.w3.org/2001/XMLSchema#string

P698

25599163

http://www.w3.org/2001/XMLSchema#string